Nicotine + Placebo
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Mar 1, 2009 → Jun 1, 2010
NCT ID
NCT00882375About Nicotine + Placebo
Nicotine + Placebo is a pre-clinical stage product being developed by Johnson & Johnson for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT00882375. Target conditions include Smoking Cessation.
What happened to similar drugs?
17 of 20 similar drugs in Smoking Cessation were approved
Approved (17) Terminated (0) Active (3)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00882375 | Pre-clinical | Completed |
Competing Products
20 competing products in Smoking Cessation